Memorial Sloan Kettering researchers are relentlessly exploring every aspect of cancer — from basic investigations of cells and molecules to clinical trials of new treatments and population-wide studies of the disease. While our core mission is to translate this knowledge into new strategies to control cancer, many of our investigators are also making scientific progress against other diseases and conditions.

Below are some examples of discoveries and advances that recently were made in our laboratories and clinics, and featured in our blog, On Cancer.

and/or

390 News Items found

In The Lab

Ro Versus Musashi: How One Molecule Can Turn Cancer Cells Back to Normal

Researchers identify a compound that appears to eliminate tumor cells in a dish and in mice.

An illustration of a samurai and a crab.

In the Lab

Checkpoint Challenge: When Releasing Immune Cell Brakes Is Not Enough to Stop Cancer

Scientists have learned that cutting a T cell’s brakes can have unexpected consequences.

Immune cells surrounding a cancer cell

In The Lab

Computational “Hive Mind” Helps Scientists Solve an Enzyme’s Cryptic Movements

The breakthrough gives an unprecedented look at the varied and shifting poses of a protein in action.

Two clusters of colored blobs with a diagram in the middle

Roundup

Highlights from ASCO 2019: Progress in Treating Cancer in Children

MSK Kids doctors report advances in treating pediatric cancers at the 2019 meeting of the American Society of Clinical Oncology.

Crowd shot at ASCO 2019

In The News

ASCO 2019: PARP Inhibitors Benefit People with Pancreatic Cancer Who Have a BRCA Mutation

Results from a large phase III clinical trial unveiled at this year’s ASCO meeting identify an effective targeted therapy for a subset of people with pancreatic cancer.

MSK medical oncologist Eileen O'Reilly with a patient

Q & A

What Can Be Learned from a Negative Clinical Trial? Findings from a Sarcoma Study at ASCO 2019

At the ASCO meeting in Chicago, MSK medical oncologist William Tap talked about disappointing results from a new sarcoma drug, which didn’t increase survival.

Medical oncologist William Tap

Feature

How Do Immune Cells Kill Their Prey?

When an immune cell faces a foe, it has more than chemical weapons at its disposal.

An illustration of an immune cell killing a cancer cell, and a snake attacking a mouse

Q & A

Why Do Germs Become Resistant to Antibiotics? An MSK Program Is Focused on Avoiding this Problem

Learn how MSK’s Antibiotic Management Program is leading the way in ensuring that antibiotics and other antimicrobial drugs are used responsibly.

Photo of many different types of pills

In The Lab

Scientists Home In On “Equation” for Muscle Cell Size

A new study in flies reveals a previously unknown type of cooperation at work in muscle cells.

Mutlinucleated muscle cells from flies

Finding

One Patient’s Exceptional Response Leads to a Surprising Discovery about Immunotherapy

MSK researchers learn that some cancers may respond to checkpoint inhibitor drugs because of changes called gene fusions.

Drawing of one human figure set apart from a group of others.